Figure S2. Kaplan-Meier curves stratified by the status of DNMT3A mutations for overall survival among the 421 SF3B1-wild type MDS patients (A) and among the 48 SF3B1-mutated MDS patients (B). This evidence concerns the gene SF3B1 and myelodysplastic syndrome.